See also this year's filing and all EDGAR filings for this company.
PDF Report 0001316175_2018_Anthera_Pharmaceuticals_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001316175, Anthera Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 3,191,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 482,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 4,711,000 |
| 5 | LiabilitiesNoncurrent | 4,457,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,335,074 |
| 9 | ResearchAndDevelopmentExpense | 33,875,644 |
| 10 | remainder_Expenses | -152,386 |
| 11 | remainder_Revenues | 47,961 |
| 12 | remainder_NetIncome | 21,993,182 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 3,673,000 |
| 1 | Liabilities | 9,168,000 |
| 2 | Expenses | 42,058,332 |
| 3 | Revenues | 47,961 |
| 4 | StockholdersEquity | -5,495,000 |
| 5 | NetIncome | -20,017,189 |
| 6 | ComprehensiveNetIncome | -20,017,189 |
| 7 | BaseVar | 38,470,238 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -4.98 |
| 9 | EconomicCapitalRatio | 0.193 |
Edgar->Model Mapping
Feature Distribution
Change over Time
